Clinical Trials for Newave Pharmaceutical

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Newave Pharmaceutical

Clinical Trials (4)

NCT06978088
LP-168 and Obinutuzumab for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Variants of This
PHASE2Recruiting
34 participants
Started: Jun 1, 2025 · Completed: Jun 1, 2034
4 conditions2 sponsors1 location
NCT04771572
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
PHASE1Recruiting
100 participants
Started: Aug 23, 2021 · Completed: Oct 1, 2025
13 conditions1 sponsor8 locations
NCT04775745
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
PHASE1Recruiting
60 participants
Started: Jul 19, 2021 · Completed: Dec 31, 2025
7 conditions1 sponsor4 locations
NCT04139434
Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AML
PHASE1Active, not recruiting
36 participants
Started: Jul 6, 2020 · Completed: Jan 31, 2025
6 conditions1 sponsor7 locations